Objectives: Diabetes mellitus and thyroid dysfunction are the two most common endocrinopathies seen in general population. The study was done to determine whether there is any co-occurence of thyroid hormonal status alternating in newly diagnosed type 2 diabetes mellitus.
Patients and Methods:
This Cross-sectional study which was carried out at National Institute of Nuclear Medicine and Allied Sciences and outpatient Department (OPD) of Endocrinology of Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka during the period January 2015 to July 2016. A total of 98 newly diagnosed type 2 diabetic patients (Group I) and 98 healthy individuals (Group II) were enrolled in this study purposively. After taking written consent, history of the study subjects was taken and clinical checkup was done. Age of the subjects of both the group were 30 years and above. Glycemic status of both the group was assessed by measuring fasting blood sugar, blood sugar two hours after 75 gm oral glucose and blood for HbA1C. Patients with type 1 and other form of diabetes mellitus and any condition that may impair glycemic control were excluded from the study. Thyroid hormonal status of both the group was evaluated by measuring patients' serum TSH by Immunoradiometric Assay (IRMA) and serum FT3 and serum FT4 by Radioimmunoassay (RIA) method in NINMAS. All the data were digitized and analyzed using SPSS -22.0 software.
Results:
In this study, mean age of the patients was 46.0 ± 9.7 years and 45.5 ± 7.7 years in group I and group II respectively. Male female ratio was 1:1.45 in group I and 1:1.08 in group II. Fasting blood sugar, blood sugar two hours after 75 gm oral glucose and HbA1c were significantly higher in group I than that of group II. Mean TSH, FT3 and FT4 were 2.37 ± 3.86 mIU/L, 6.35 ± 2.41 pmol/L and 15.79 ± 5.41 pmol/L respectively in group I whereas 2.28 ± 2.67 mIU/L, 6.59 ± 1.83 pmol/L and 16.25 ± 3.46 pmol/L respectively in group II. But there was no statistical significant difference between group I and group II. In group I, sixteen patients had thyroid disorder (seven had hyperthyroidism and nine had hypothyroidism). In group II, five patients had thyroid disorder (two had hyperthyroidism and three had hypothyroidism). Thyroid disorders are also very common in general population and it is second only to DM to affect the endocrine system (5). Thyroid hormones T3 and T4 have significant effect on blood glucose homeostasis, involved in cellular metabolism and cause functional derangement of cell. Hypothyroidism can result in hypoglycemia and hyperthyroidism results hyperglycemia (6).
The first report showing association between diabetes and thyroid dysfunction was published in 1979 (7) . Since then a number of studies have estimated the prevalence of thyroid dysfunction among diabetes patients to varying from 2.2% to 17%, the most common disorders being subclinical hypothyroidism (8) .
Thyroid disorders have significant effect on blood glucose levels. Studies have found that diabetes mellitus and thyroid disorders tend to co-occur in patients. Almost one third of people with type 1 diabetes have found to have thyroid disease. In type 1 diabetes thyroid dysfunction may be due to underlying genetic predisposition which leads to the coexistence of autoimmune destruction of pancreatic islets cells as well as thyrocytes (9) . In type 2 diabetes mellitus, the association with thyroid dysfunction is largely unexplained, although it may relate to old age, and also possibly the fact that, some type 2 diabetes mellitus actually type 1 diabetes mellitus patients who have a very slow onset and so have the same genetic predisposition as type 1 diabetes mellitus (10) . As diabetes mellitus is a major health problem, any disorders that may even be weakly associated with it, needs special attention.
PATIENTS AND METHODS
This Cross-sectional analytical study was carried out at National Institute of Nuclear Medicine and Allied Sciences (NINMAS) and OPD of Endocrinology of Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka over a period of 19 months from January 2015 to July 2016. A total of 98 newly diagnosed type 2 diabetic patients (Group I) and 98 healthy individuals (Group II) were enrolled in this study purposively. After taking written consent, history of the study subjects was taken and clinical checkup was done. Age of the subjects of both the group were 30 years and above. Glycemic status of both the group was assessed by measuring fasting blood sugar, blood sugar two hours after 75 gm oral glucose (2 HA 75 GO) and blood for HbA1C. Patients with type 1 and other form of diabetes mellitus and any condition that may impair glycemic control were excluded from the study. Thyroid hormonal status of both the group was evaluated by measuring patient's serum TSH by Immunoradiometric Assay (IRMA) and serum FT3 and serum FT4 by Radioimmunoassay (RIA) method in NINMAS. All the data were digitized and analyzed using SPSS -22.0. Quantitative data were expressed as mean and standard deviation and qualitative data were expressed as frequency distribution and percentage. Association between categorical variables was analyzed by chi-squared test and continuous variable by independent sample t-test. Correlation was done by Pearson correlation coefficient test, as for normal distribution. Normality of distribution was seen by Shiparo-Wilk test. For all statistical tests, p value < 0.05 was considered as statistically significant. Table 1 shows that, mean age of the patients were 46.0 ± 9.7 years and 45.5 ± 7.7 years in group I and group II respectively. There was no significant difference between two groups. In both groups, female were predominant. In group I, 58 (59.2%) and 40 (40.8%) study populations were female and male respectively, similarly in group II, 51 (52.0%) and 47 (48.0%) study populations were female and male respectively. Both systolic and diastolic BP were significantly higher in group I than that of group II but there was no significant difference in pulse and BMI between two groups (Table 2) . Fasting blood sugar, blood sugar 2HA 75GO and HbA1c were significantly higher in group I than that of group II (Table 3) . From Table 4 , it is found that mean TSH, FT 3 and FT 4 were 2.37 ± 3.86 mIU/L, 6.35 ± 2.41 pmol/L and 15.79 ± 5.41 pmol/L respectively in group I whereas 2.28 ± 2.67 mIU/L, 6.59 ± 1.83 pmol/L and 16.25 ± 3.46 pmol/L respectively in group II (Table 4) . But there was no statistical significant difference between group I and group II. Table 5 shows that, seven (7.1%) and two (2.0%) patients had hyperthyroidism in group I and group II respectively. On the other hand nine (9.2%) and three (3.1%) patients had hypothyroidism in group I and group II. There was statistically significant difference between group I and group II in respect to thyroid disorders present or absent. Chi-square test was done to measure the level of significance. Pearson correlation coefficient test was done for normal distribution.
RESULTS

DISCUSSION
In this study, mean age of the patients were 46.0 ± 9.7 years and 45.5 ± 7.7 years in group I and Group II respectively. There was no significant difference between group I and group II. In both groups, female were predominant. In a similar study, Vinu et al. (5) have taken same number of male and female in case and control group and the mean age was slightly lower than this study. In another study, mean age of diabetic subject 43.16 ± 5.06 years and non-diabetic subjects 45.37 ± 6.19 years (11) which were almost similar to the present study. Both systolic and diastolic BP was significantly higher in group I than that of group II but there was no significant difference in pulse and BMI between two groups.
Mean FBS (10.17 ± 1.84 mmol/L and 5.43 ± 0.57 mmol/L in group I and group II respectively) and mean blood sugar 2HA75GO (16.12 ± 2.32 mmol/L and 7.97 ± 0.87 mmol/L in group I and group II respectively) are higher in this study both in diabetic and nondiabetic individuals than the study conducted by Saha et al. ( FBS 8.24 ± 2.58 mmol/L in diabetic subjects and 5.16 ± 0.80 mmol/L in non-diabetic subjects and blood sugar 2HA 75GO 12.86 ±5 .25 mmol/L and 6.51 ± 0.95 mmol/L in diabetic and non-diabetic subjects respectively) (6). HbA1c (10.11 ± 1.08) % and (5.52 ± 0.52) % in group I and group II respectively is higher in this study both in diabetic and non-diabetic individuals than the study conducted by Vikhe et al. (7. 38 ± 0.72% and 5.12 ± 0.21 in diabetic and non-diabetic subjects respectively (11). Saha et al. (6) found HbA1C in diabetic and non-diabetic subjects are almost same as present study.
In this study, mean TSH was slightly higher and mean In this study, Out of 98 type 2 diabetic patients, 16 (16.3%) showed thyroid disorder (7.1% had hyperthyroidism and 9.2% had hypothyroidism) and out of 98 normal healthy individuals five (5.1%) showed thyroid disorder (2.0% had hyperthyroidism and 3.1% had hypothyroidism). There was statistically significant difference between group I and group II (p = 0.039).
These findings agree with the report of Vinu et al. (5) and Alam et al. (14) . The prevalence of thyroid dysfunction among diabetes patients varies from 2.2 to 17.0 %, the most common disorder being subclinical hypothyroidism (8) . However, few studies have also estimated much higher prevalence of thyroid dysfunction in diabetes i.e. 31 % and 46.5% respectively (15) . 
